Biodesix (BDSX) Stock Statistics & Valuation Metrics

Biodesix has a market cap or net worth of $43.95M. The enterprise value is $501.12M.

Biodesix has 146,563,030 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biodesix’s return on equity (ROE) is -2.06 and return on invested capital (ROIC) is -40.88%.

The current PE Ratio of Biodesix is -4.62. Biodesix’s PEG ratio is -0.07.

In the last 12 months, Biodesix had revenue of 71.32M and earned -42.93M in profits. Earnings per share was -0.33.

In the last 12 months, operating cash flow was -41.96M and capital expenditures -3.24M, giving a free cash flow of -45.20M billion.

Biodesix pays an annual dividend of ―, resulting in a dividend yield of ―

Biodesix upcoming earnings date is Aug 12, 2025, TBA Not Confirmed.

Biodesix as a current ratio of 2.76, with Debt / Equity ratio of 154.57%

In the past 12 months, Biodesix has paid 0.00 in taxes.

Biodesix EV to EBITDA ratio is -8.01, with an EV/FCF ratio of -4.51.

Biodesix has $17.60M in cash and marketable securities with $62.28M in debt, giving a net cash position of $44.68M billion.

Gross margin is 62.96%, with operating margin of -48.37%, and net profit margin of -60.19%.

The average price target for Biodesix is $1.88, which is 11.43% higher than the current price. The consensus rating is Strong Buy